Scripps Research Discovery Leads to Broad Potential Applications in CovX-Pfizer Deal

LA JOLLA, Calif.--(BUSINESS WIRE)--Dec 19, 2007 - A catalytic antibody discovery made at The Scripps Research Institute has formed the basis of the upcoming acquisition of biotechnology venture CovX by pharmaceutical giant Pfizer, Inc. "I am deeply...

Comments

• Find It

• Recently Written

  • Link Between Hepatitis C And Insulin Resistance Surprises Scientists
  • N.L. health staff slow on drug errors
  • Study casts doubts on safety of invisible nano-sunscreens
  • Catalina Marketing Hires Johnson & Johnson Executive to Lead Health Care Services Division
  • Health Canada Launches the Translated Eating Well with Canada’s Food Guide for First Nations, Inuit and Métis in Four Aboriginal Languages
  • Lilly moves target ethics, compliance
  • GSK CEO Andrew Witty Dedicates albendazole Facility in Nashik to WHO?s Global Programme to Eliminate LF
  • Cardiff University and Merck Serono Launch International Survey For Couples Trying To Conceive
  • Exelixis Announces Restructuring
  • Nabi Closes License Deal With Glaxosmithkline

• Categories

  • News

• Monthly Archives

  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • December 1969

• Blogroll

  • Attorney Daily » Drug Injury News
  • Dangerous Drug Lawyer
  • Drugs.com - Pharma News
  • Health Canada RSS
  • Lawyers and Settlements :: Drugs/Medical
  • Medication News
  • MedWatch Safety Alert RSS Feed

• Admin

  • Register
  • Log in
  • XHTML

Copyright © 2010 Drug Injury News